DAIC

JANUARY 15, 2024

Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 6, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Overall outcomes and the escalation rate for home hospital admissions for heart failure (HF) are not known. Unexpected mortality was defined as mortality excluding those who desired to pass away at home on admission or transitioned to hospice.

Heart Failure 40

Heart Failure Hospital Outcomes Inpatient 40

Journal of the American Heart Association

JANUARY 9, 2024

BackgroundSoluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. P=0.01) for right heart failure, both per 10‐unit sST2 increase. The sST2 instantaneous change was not predictive for survival or right heart failure (P=0.99 andP=0.94, respectively).

Heart Failure 45

Heart Failure Research Outcomes 45

European Journal of Heart Failure

DECEMBER 13, 2023

Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. Abstract Aims There is uncertainty about the definition of iron deficiency (ID) and the association between ID and prognosis in patients with advanced heart failure. Non-scaled VENN diagram.

Heart Failure 40

Heart Failure Heart Transplant Transplant Tricuspid 40

European Journal of Heart Failure

NOVEMBER 24, 2023

The different risk of new-onset, chronic, worsening, and advanced heart failure. CI, confidence interval; HF, heart failure; OR, odds ratio. Abstract Aims Heart failure (HF) is a chronic and progressive syndrome associated with a poor prognosis. 9.89) for CHF, 21.15% (95% CI 17.78–24.95)

Heart Failure 40

Heart Failure Hospital Outcomes Research 40

European Journal of Heart Failure

DECEMBER 28, 2023

Abstract Background and aim Heart Failure with preserved Ejection Fraction (HFpEF) remains under-diagnosed in clinical practice despite accounting for nearly half of all Heart Hailure (HF) cases. We collected demographic, clinical, echocardiographic and outcome data from the EHR.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Echocardiogram Article 40

Heart BMJ

DECEMBER 20, 2023

In a cohort of patients with liver metastases of midgut neuroendocrine tumours (NETs), we aimed to describe the perioperative management and short-term outcomes of CHD. Results Out of 43 (16%) consecutive patients with severe CHD and liver metastases of midgut NETs, 79% presented with right-sided heart failure.

Heart Disease 40

Heart Disease Tricuspid Outcomes Heart Failure 40

Open Heart

FEBRUARY 17, 2024

Objective To evaluate stress, depression and quality of life among community-dwelling patients with heart failure (HF) and evaluate their effect on perceived medication adherence in a socioeconomically challenged setting.

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor COVID-19 40

Journal of the American Heart Association

DECEMBER 29, 2023

BackgroundPulmonary hypertension (PH) is highly prevalent in patients with heart failure with preserved ejection fraction (HFpEF), and it is a strong predictor of adverse outcomes. The patients underwent invasive cardiac catheterization and simultaneous echocardiography at rest and during exercise.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Heart Failure Hypertension 40

Stroke Journal

JANUARY 30, 2025

Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.

Stroke 40

Stroke Strokes Atrial Fibrillation Risk Factors 40

Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundThis realworld evidence study compared risks of cardiovascular events in hospital settings among patients with chronic kidney disease (CKD) with and without hyperkalemia.Methods and ResultsAdults with CKD stages 3b/4 with and without hyperkalemia were identified from Optum's deidentified Market Clarity Data (January 2016August 2022).

Kidney Disease 45

Kidney Disease Arrhythmia Myocardial Infarction Atrial Fibrillation 45

Circulation

NOVEMBER 11, 2024

Primary and secondary outcomes included all-cause mortality and changes in BNP levels, respectively.Results:The study included 1,626 patients. Conclusion:The study utilized unsupervised analysis of longitudinal echocardiographic data to identify three distinct HFpEF trajectories, each associated with unique clinical features and outcomes.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Outcomes Circulation 40

DAIC

FEBRUARY 29, 2024

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. Overall, mean age was 76.7±10.6

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Risk Factors Tricuspid 40

Circulation: Cardiovascular Interventions

APRIL 7, 2025

However, the association between the extent of cardiac damage at the time of AVR and health care costs and resource utilization has never been described.METHODS:The Optum de-identified Market Clarity database was used to identify patients with aortic stenosis treated with AVR between 2016 and 2022. in stage 0, 17.1% in stage 1, 37.3%

Aortic valve 40

Aortic valve Aortic Heart Failure Quality of Life 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. Patients included were of Hispanic origin presenting between 2012 and 2022 who underwent thrombectomy for acute ischemic stroke. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

International Journal of Cardiovascular Sciences

JULY 18, 2023

The Award will refer to articles published in 2021 and 2022. The Award will be given to the Brazilian authors of the best Original Article published in the ABC Cardiol and IJCS journals for the years 2021 and 2022, and to Brazilian authors of the best Original Article published in the ABC Imagem and ABC HF journals in 2022.

Article 52

Article Plaque Heart Failure Research 52

Heart BMJ

MARCH 12, 2024

Introduction Takotsubo syndrome (TTS) is an acute heart failure syndrome, featured by transient left ventricular systolic dysfunction. The primary outcome was TTS recurrence. Recurrences of TTS are not infrequent and there is no standard preventive therapy.

ACE Inhibitor 52

ACE Inhibitor Heart Failure Outcomes 52

Journal of Cardiovascular Electrophysiology

FEBRUARY 13, 2024

Abstract Introduction Clinical outcomes of long-term ventricular septal pacing (VSP) without His-Purkinje capture remain unknown. This study evaluated the differences in clinical outcomes between conduction system pacing (CSP), VSP, and right ventricular pacing (RVP). Results Among 1016 patients (age 73.9 ± 11.2

Bradycardia 40

Bradycardia Physiology Pacemaker Heart Failure 40

Circulation

NOVEMBER 11, 2024

Kaplan-Meier estimated of survival and freedom from heart failure re-hospitalization were 97.8% female, mean TRISCORE 5.3±2.1). Six-minute walk test increased by 31.9m(304.3±81.2, p<0.001), and overall Kansas City Cardiomyopathy Questionnaire (KCCQ) score improved by 7.6 p<0.001).

Tricuspid 40

Tricuspid Quality of Life Heart Failure Cardiomyopathy 40

International Journal of Cardiovascular Sciences

JULY 11, 2024

There will be an award for the most cited national manuscript in the last two years, namely: the most cited article published in 2021 and 2022 in 2023, for the journals ABC Cardiol and IJCS; and the most accessed in 2023 for the journals ABC Imagem and ABC HF. for enrollment in courses at the Heart University.

Article 52

Article Plaque Heart Failure Cardiomyopathy 52

Open Heart

MARCH 16, 2023

Hence, our aim was to assess the relationship between N-terminal pro-B type natriuretic peptide (NT-pro BNP) along with appropriate ICD shock and all-cause mortality in order to improve the stratification process of patients with heart failure with reduced ejection fraction (HFrEF) being considered for primary preventive ICD therapy.

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Introduction:A rising prevalence of stroke in young patients was noticed in recent years. were male, and 60.4%

Stroke 40

Stroke Strokes Coronary Artery Disease Risk Factors 40

Journal of Cardiovascular Electrophysiology

JANUARY 30, 2024

Abstract Introduction In hypertrophic cardiomyopathy (HCM), atrial fibrillation (AF) has historically been regarded to have a deleterious impact on clinical course, strongly associated with progressive heart failure (HF) symptoms. Therefore, we evaluated the impact of AF on QoL utilizing patient reported outcome measures (PROMs).

Quality of Life 40

Quality of Life Atrial Fibrillation Cardiomyopathy Heart Failure 40

Stroke Journal

FEBRUARY 1, 2024

We sought to evaluate the spoke hospital door in-door out (DIDO) times for patients transferred to our hub center for EVT.Methods:Individuals who first presented with LVO to a spoke hospital and were then transferred to the hub for EVT were retrospectively identified from a prospectively maintained database from January 2019 to November 2022.

Stroke 40

Stroke Strokes Thrombolysis Atrial Fibrillation 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We sought to evaluate the spoke hospital door in‐door out (DIDO) times for patients transferred to our hub center for EVT.MethodsIndividuals who first presented with LVO to a spoke hospital and were then transferred to the hub for EVT were retrospectively identified from a prospectively maintained database from January 2019 to November 2022.

Stroke 40

Stroke Strokes Thrombolysis Atrial Fibrillation 40

Stroke Journal

JANUARY 30, 2025

Introduction:Pediatric heart transplant (PHT) recipient survival has improved. Yet, neurologic morbidity related to heart failure and its treatment persist. It can affect the functional outcome, increase risk of major adverse events, prolong LOS and increase the use of rehabilitation therapies (RT).

Heart Transplant 40

Heart Transplant Transplant Pediatrics Stroke 40

Dr. Smith's ECG Blog

AUGUST 6, 2024

As a result, this 45-year old man did not experince any delay in treatment — and a large diagonal branch of the LAD was stented with good outcome. As a result — the heart rate of ~115/minute in ECG #1 is a worrisome finding. It suggests a more extensive MI, potentially with resultant heart failure.

Chest Pain 104

Chest Pain Ischemia Pericarditis Tachycardia 104

DAIC

MARCH 26, 2025

Food and Drug Administration (FDA) accepted its supplemental new drug application (sNDA) and granted Priority Review designation for KERENDIA(finerenone) for the treatment of adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF).

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

Dr. Smith's ECG Blog

OCTOBER 6, 2023

Thus, this ECG predicts poor myocardial perfusion and poor outcome. Small vessel occlusion is measured by "blush" on the angiogram, and codified by TIMI Myocardial Perfusion (TMP) Grading. The best predictor of good blush and high TMP is the ECG, specifically resolution of ST Elevation on the ECG.

Aneurysm 66

Aneurysm Chest Pain Cardiogenic Shock Blog 66

DAIC

APRIL 3, 2024

healthcare providers can now detect Low EF, a key heart failure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heart failure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2

Heart Failure 111

Heart Failure Cardiomyopathy AFIB Hospital 111

DAIC

JULY 25, 2024

FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heart failure. Leslie Miller, MD , trial investigator at the CHF Heart Function Clinic at BayCare Morton Plant Hospital in Clearwater, Florida and a member of the CardiAMP Heart Failure II Study Executive Steering Committee. “As

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

FEBRUARY 22, 2024

The study, which is testing a novel rehabilitation program designed for older patients hospitalized with acute heart failure, is funded by a five-year, $30 million grant , awarded to Wake Forest University School of Medicine in 2022 by the National Institute of Aging, part of the National Institutes of Health.

Heart Failure 105

Heart Failure Research Preserved Ejection Fraction Hospital 105

Journal of the American Heart Association

MARCH 21, 2025

Though the severe morbidity of disease in men is well established, longitudinal studies describing the trajectory of cardiovascular disease in both sexes are lacking.Methods and ResultsData were from the International Danon Disease Registry and includes retrospective data on 116 patients who provided informed consent between 2005 and 2022.

Heart Failure 81

Heart Failure Outcomes Cardiovascular Disease 81

DAIC

MARCH 31, 2025

If left untreated, certain arrhythmias can damage the heart, brain, or other organs 4 and increase the risk of stroke or death. 3 billion per year, 8 while heart failure costs could reach $70 billion by 2030. Published March 24, 2022. Circulation: Heart Failure. www.nhlbi.nih.gov. Accessed April 25, 2024.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

Journal of the American Heart Association

DECEMBER 14, 2024

Journal of the American Heart Association, Volume 13, Issue 24 , December 17, 2024. The main outcome was the composite of allcause mortality and first HF hospitalization. EAT volume exhibited a strong unadjusted association with the composite outcome (hazard ratio per 1 mL/m2[HR], 1.57 [95% CI, 1.401.76],P<0.001).

Preserved Ejection Fraction 58

Preserved Ejection Fraction Heart Failure Hospital Outcomes 58

DAIC

JUNE 7, 2024

Two analyses were presented as late-breaking data at the New York Valves Structural Heart Summit, including a secondary analysis of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial and an expanded analysis of bioprosthetic valve dysfunction (BVD) outcomes from a CoreValve-Evolut pooled analysis. iii Am Heart Assoc.

TAVR 111

TAVR Aortic valve Aortic Stenosis 111